Oxurion’s Funding Round

Horn & Co. represented Pontifax Ventures on the deal.

Pontifax Venture Capital and Kreos Capital provided €10 million debt financing to Oxurion. 

Oxurion is focused on building a leading global franchise in the treatment of retinal vascular disorders based on the successful development of its two novel therapeutics.

The Horn & Co. team was led by Yonatan Levinstein (Picture).

Involved fees earner: Yonatan Levinstein – Horn & Co. Law;

Law Firms: Horn & Co. Law;

Clients: Pontifax;